Focus Partners Wealth
PRCT icon

Focus Partners Wealth’s Procept Biorobotics PRCT Stock Holding History

Focus Partners Wealth’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$624K Sell
24,931
-168
-0.7% -$4.73K ﹤0.01% 1820
2025
Q4 		$790K Sell
25,099
-401
-2% -$13.3K ﹤0.01% 1738
2025
Q3 		$910K Buy
+25,500
New +$1.16M ﹤0.01% 1325
2025
Q2 		– Sell
-23,247
Closed -$1.35M – 2112
2025
Q1 		$1.35M Buy
23,247
+69
+0.3% +$4.71K ﹤0.01% 964
2024
Q4 		$1.87M Buy
23,178
+77
+0.3% +$6.58K ﹤0.01% 849
2024
Q3 		$1.84M Buy
+23,101
New +$1.64M 0.01% 782

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Focus Partners Wealth's PRCT Position: Q1 2026 in Review

Focus Partners Wealth reduced its Procept Biorobotics (PRCT) stake by 0.67% in Q1 2026, selling an estimated $4.73K and leaving 24,931 shares worth $624K. The position accounts for ﹤0.01% of the portfolio, ranked #1820.

Focus Partners Wealth first reported a position in PRCT in Q3 2024 and has held it in 6 quarters since. The position peaked at $1.87M in Q4 2024. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Focus Partners Wealth held 24,931 shares of Procept Biorobotics worth $624K as of Q1 2026.
  • Focus Partners Wealth sold 168 Procept Biorobotics shares in Q1 2026, an estimated $4.73K.
  • Procept Biorobotics made up ﹤0.01% of Focus Partners Wealth's portfolio in Q1 2026, its #1820 holding.
  • Focus Partners Wealth first reported a position in Procept Biorobotics in Q3 2024 and has held it in 6 quarters since.
  • Focus Partners Wealth's Procept Biorobotics position peaked at $1.87M in Q4 2024.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.